- Home
- SMSI vs CPIX Comparison
SMSI vs CPIX Comparison
Compare SMSI & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- CPIX
- Stock Information
- Founded
- SMSI 1982
- CPIX 1999
- Country
- SMSI United States
- CPIX United States
- Employees
- SMSI N/A
- CPIX N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- CPIX Biotechnology: Pharmaceutical Preparations
- Sector
- SMSI Technology
- CPIX Health Care
- Exchange
- SMSI Nasdaq
- CPIX Nasdaq
- Market Cap
- SMSI 16.2M
- CPIX 17.2M
- IPO Year
- SMSI 1995
- CPIX 2009
- Fundamental
- Price
- SMSI $0.81
- CPIX $1.14
- Analyst Decision
- SMSI Strong Buy
- CPIX
- Analyst Count
- SMSI 1
- CPIX 0
- Target Price
- SMSI $5.00
- CPIX N/A
- AVG Volume (30 Days)
- SMSI 178.5K
- CPIX 87.0K
- Earning Date
- SMSI 11-13-2024
- CPIX 11-07-2024
- Dividend Yield
- SMSI N/A
- CPIX N/A
- EPS Growth
- SMSI N/A
- CPIX N/A
- EPS
- SMSI N/A
- CPIX N/A
- Revenue
- SMSI $24,178,000.00
- CPIX $36,785,442.00
- Revenue This Year
- SMSI N/A
- CPIX N/A
- Revenue Next Year
- SMSI $74.44
- CPIX N/A
- P/E Ratio
- SMSI N/A
- CPIX N/A
- Revenue Growth
- SMSI N/A
- CPIX N/A
- 52 Week Low
- SMSI $0.52
- CPIX $1.07
- 52 Week High
- SMSI $7.52
- CPIX $2.36
- Technical
- Relative Strength Index (RSI)
- SMSI 42.15
- CPIX 38.35
- Support Level
- SMSI $0.70
- CPIX $1.08
- Resistance Level
- SMSI $0.93
- CPIX $1.21
- Average True Range (ATR)
- SMSI 0.07
- CPIX 0.09
- MACD
- SMSI 0.01
- CPIX 0.00
- Stochastic Oscillator
- SMSI 47.83
- CPIX 26.92
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. It offers multi-platform, modular solutions such as SafePath; CommSuite; and ViewSpot. The company's only reportable segment is Wireless. Its Wireless segment sells to large wireless carriers, cable operators, and OEMs.
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.